ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral GnRH Drugs Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-23D18054
Home | Market Reports | Health| Pharmacy
Global Oral GnRH Drugs Market Research Report 2024
BUY CHAPTERS

Global Oral GnRH Drugs Market Research Report 2024

Code: QYRE-Auto-23D18054
Report
October 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
ASKA Pharmaceutical
Pfizer Inc
Sumitomo Pharma
ObsEva
JW Pharmaceutical

Oral GnRH Drugs Market

Oral GnRH drugs are medications designed to influence the gonadotropin-releasing hormone (GnRH) pathway through oral administration. Unlike traditional injectable GnRH analogs, oral formulations are intended to be taken by mouth and are typically used to manage conditions such as endometriosis or prostate cancer.
The global Oral GnRH Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The development of oral GnRH drugs represents a significant advancement in the field of hormone regulation and treatment. Traditionally, GnRH analogs required injection due to their peptide nature, which made oral administration impractical because they would be broken down in the digestive system. However, ongoing research and technological innovations have led to the development of oral formulations that can effectively deliver these drugs into the bloodstream. This trend reflects a broader movement towards more convenient, patient-friendly treatments that improve adherence and quality of life.
Recent advancements have focused on creating oral GnRH antagonists, such as Elagolix (Orilissa) and Relugolix (Orgovyx). These drugs are designed to block the action of GnRH, thereby reducing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This approach has shown promise in treating hormone-sensitive conditions like endometriosis and prostate cancer, offering an oral alternative to injectable treatments. The development of these medications highlights a shift towards more accessible treatments that maintain efficacy while minimizing the need for invasive procedures.
Looking forward, research continues to explore new formulations and delivery systems for oral GnRH drugs. Scientists are investigating ways to enhance the stability and bioavailability of these drugs in the gastrointestinal tract, which could expand their use to a broader range of conditions. Additionally, the ongoing development of oral GnRH agonists and other innovative therapies aims to provide more options for managing various endocrine disorders, reflecting a trend towards personalized and less burdensome treatment regimens.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral GnRH Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral GnRH Drugs.
The Oral GnRH Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral GnRH Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral GnRH Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral GnRH Drugs Market Report

Report Metric Details
Report Name Oral GnRH Drugs Market
Segment by Type
  • Elagolix
  • Relugolix
  • Linzagolix
  • Others
Segment by Application
  • Endometriosis
  • Uterine Fibroids
  • Menorrhagia
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbvie, ASKA Pharmaceutical, Pfizer, Sumitomo Pharma, ObsEva, JW Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral GnRH Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral GnRH Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oral GnRH Drugs Market report?

Ans: The main players in the Oral GnRH Drugs Market are Abbvie, ASKA Pharmaceutical, Pfizer, Sumitomo Pharma, ObsEva, JW Pharmaceutical

What are the Application segmentation covered in the Oral GnRH Drugs Market report?

Ans: The Applications covered in the Oral GnRH Drugs Market report are Endometriosis, Uterine Fibroids, Menorrhagia, Other

What are the Type segmentation covered in the Oral GnRH Drugs Market report?

Ans: The Types covered in the Oral GnRH Drugs Market report are Elagolix, Relugolix, Linzagolix, Others

1 Oral GnRH Drugs Market Overview
1.1 Product Definition
1.2 Oral GnRH Drugs by Type
1.2.1 Global Oral GnRH Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Elagolix
1.2.3 Relugolix
1.2.4 Linzagolix
1.2.5 Others
1.3 Oral GnRH Drugs by Application
1.3.1 Global Oral GnRH Drugs Market Value by Application (2024-2030)
1.3.2 Endometriosis
1.3.3 Uterine Fibroids
1.3.4 Menorrhagia
1.3.5 Other
1.4 Global Oral GnRH Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral GnRH Drugs Revenue 2019-2030
1.4.2 Global Oral GnRH Drugs Sales 2019-2030
1.4.3 Global Oral GnRH Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral GnRH Drugs Market Competition by Manufacturers
2.1 Global Oral GnRH Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral GnRH Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral GnRH Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oral GnRH Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral GnRH Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral GnRH Drugs, Product Type & Application
2.7 Global Key Manufacturers of Oral GnRH Drugs, Date of Enter into This Industry
2.8 Global Oral GnRH Drugs Market Competitive Situation and Trends
2.8.1 Global Oral GnRH Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral GnRH Drugs Players Market Share by Revenue
2.8.3 Global Oral GnRH Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral GnRH Drugs Market Scenario by Region
3.1 Global Oral GnRH Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral GnRH Drugs Sales by Region: 2019-2030
3.2.1 Global Oral GnRH Drugs Sales by Region: 2019-2024
3.2.2 Global Oral GnRH Drugs Sales by Region: 2025-2030
3.3 Global Oral GnRH Drugs Revenue by Region: 2019-2030
3.3.1 Global Oral GnRH Drugs Revenue by Region: 2019-2024
3.3.2 Global Oral GnRH Drugs Revenue by Region: 2025-2030
3.4 North America Oral GnRH Drugs Market Facts & Figures by Country
3.4.1 North America Oral GnRH Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral GnRH Drugs Sales by Country (2019-2030)
3.4.3 North America Oral GnRH Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral GnRH Drugs Market Facts & Figures by Country
3.5.1 Europe Oral GnRH Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral GnRH Drugs Sales by Country (2019-2030)
3.5.3 Europe Oral GnRH Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral GnRH Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Oral GnRH Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral GnRH Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Oral GnRH Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral GnRH Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral GnRH Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral GnRH Drugs Sales by Country (2019-2030)
3.7.3 Latin America Oral GnRH Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral GnRH Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral GnRH Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral GnRH Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral GnRH Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral GnRH Drugs Sales by Type (2019-2030)
4.1.1 Global Oral GnRH Drugs Sales by Type (2019-2024)
4.1.2 Global Oral GnRH Drugs Sales by Type (2025-2030)
4.1.3 Global Oral GnRH Drugs Sales Market Share by Type (2019-2030)
4.2 Global Oral GnRH Drugs Revenue by Type (2019-2030)
4.2.1 Global Oral GnRH Drugs Revenue by Type (2019-2024)
4.2.2 Global Oral GnRH Drugs Revenue by Type (2025-2030)
4.2.3 Global Oral GnRH Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Oral GnRH Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral GnRH Drugs Sales by Application (2019-2030)
5.1.1 Global Oral GnRH Drugs Sales by Application (2019-2024)
5.1.2 Global Oral GnRH Drugs Sales by Application (2025-2030)
5.1.3 Global Oral GnRH Drugs Sales Market Share by Application (2019-2030)
5.2 Global Oral GnRH Drugs Revenue by Application (2019-2030)
5.2.1 Global Oral GnRH Drugs Revenue by Application (2019-2024)
5.2.2 Global Oral GnRH Drugs Revenue by Application (2025-2030)
5.2.3 Global Oral GnRH Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Oral GnRH Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbvie
6.1.1 Abbvie Company Information
6.1.2 Abbvie Description and Business Overview
6.1.3 Abbvie Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbvie Oral GnRH Drugs Product Portfolio
6.1.5 Abbvie Recent Developments/Updates
6.2 ASKA Pharmaceutical
6.2.1 ASKA Pharmaceutical Company Information
6.2.2 ASKA Pharmaceutical Description and Business Overview
6.2.3 ASKA Pharmaceutical Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 ASKA Pharmaceutical Oral GnRH Drugs Product Portfolio
6.2.5 ASKA Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Pfizer Oral GnRH Drugs Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sumitomo Pharma
6.4.1 Sumitomo Pharma Company Information
6.4.2 Sumitomo Pharma Description and Business Overview
6.4.3 Sumitomo Pharma Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sumitomo Pharma Oral GnRH Drugs Product Portfolio
6.4.5 Sumitomo Pharma Recent Developments/Updates
6.5 ObsEva
6.5.1 ObsEva Company Information
6.5.2 ObsEva Description and Business Overview
6.5.3 ObsEva Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ObsEva Oral GnRH Drugs Product Portfolio
6.5.5 ObsEva Recent Developments/Updates
6.6 JW Pharmaceutical
6.6.1 JW Pharmaceutical Company Information
6.6.2 JW Pharmaceutical Description and Business Overview
6.6.3 JW Pharmaceutical Oral GnRH Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 JW Pharmaceutical Oral GnRH Drugs Product Portfolio
6.6.5 JW Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral GnRH Drugs Industry Chain Analysis
7.2 Oral GnRH Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral GnRH Drugs Production Mode & Process
7.4 Oral GnRH Drugs Sales and Marketing
7.4.1 Oral GnRH Drugs Sales Channels
7.4.2 Oral GnRH Drugs Distributors
7.5 Oral GnRH Drugs Customers
8 Oral GnRH Drugs Market Dynamics
8.1 Oral GnRH Drugs Industry Trends
8.2 Oral GnRH Drugs Market Drivers
8.3 Oral GnRH Drugs Market Challenges
8.4 Oral GnRH Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
ASKA Pharmaceutical
Pfizer Inc
Sumitomo Pharma
ObsEva
JW Pharmaceutical
List of Tables
 Table 1. Global Oral GnRH Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Oral GnRH Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Oral GnRH Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Oral GnRH Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Oral GnRH Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Oral GnRH Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Oral GnRH Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Oral GnRH Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Oral GnRH Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral GnRH Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral GnRH Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Oral GnRH Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral GnRH Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral GnRH Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral GnRH Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Oral GnRH Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Oral GnRH Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Oral GnRH Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Oral GnRH Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Oral GnRH Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Oral GnRH Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Oral GnRH Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Oral GnRH Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Oral GnRH Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Oral GnRH Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Oral GnRH Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Oral GnRH Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Oral GnRH Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Oral GnRH Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Oral GnRH Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Oral GnRH Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Oral GnRH Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Oral GnRH Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Oral GnRH Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Oral GnRH Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Oral GnRH Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Oral GnRH Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Oral GnRH Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Oral GnRH Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Oral GnRH Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Oral GnRH Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Oral GnRH Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oral GnRH Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Oral GnRH Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Oral GnRH Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Oral GnRH Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Oral GnRH Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Oral GnRH Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Oral GnRH Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Oral GnRH Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Oral GnRH Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Oral GnRH Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Oral GnRH Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Oral GnRH Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Oral GnRH Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Oral GnRH Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Oral GnRH Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Oral GnRH Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Oral GnRH Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Oral GnRH Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Oral GnRH Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Oral GnRH Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Oral GnRH Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Oral GnRH Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Oral GnRH Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Oral GnRH Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Oral GnRH Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Oral GnRH Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Abbvie Company Information
 Table 71. Abbvie Description and Business Overview
 Table 72. Abbvie Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Abbvie Oral GnRH Drugs Product
 Table 74. Abbvie Recent Developments/Updates
 Table 75. ASKA Pharmaceutical Company Information
 Table 76. ASKA Pharmaceutical Description and Business Overview
 Table 77. ASKA Pharmaceutical Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. ASKA Pharmaceutical Oral GnRH Drugs Product
 Table 79. ASKA Pharmaceutical Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Pfizer Oral GnRH Drugs Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. Sumitomo Pharma Company Information
 Table 86. Sumitomo Pharma Description and Business Overview
 Table 87. Sumitomo Pharma Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sumitomo Pharma Oral GnRH Drugs Product
 Table 89. Sumitomo Pharma Recent Developments/Updates
 Table 90. ObsEva Company Information
 Table 91. ObsEva Description and Business Overview
 Table 92. ObsEva Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. ObsEva Oral GnRH Drugs Product
 Table 94. ObsEva Recent Developments/Updates
 Table 95. JW Pharmaceutical Company Information
 Table 96. JW Pharmaceutical Description and Business Overview
 Table 97. JW Pharmaceutical Oral GnRH Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. JW Pharmaceutical Oral GnRH Drugs Product
 Table 99. JW Pharmaceutical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Oral GnRH Drugs Distributors List
 Table 103. Oral GnRH Drugs Customers List
 Table 104. Oral GnRH Drugs Market Trends
 Table 105. Oral GnRH Drugs Market Drivers
 Table 106. Oral GnRH Drugs Market Challenges
 Table 107. Oral GnRH Drugs Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral GnRH Drugs
 Figure 2. Global Oral GnRH Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oral GnRH Drugs Market Share by Type: 2023 & 2030
 Figure 4. Elagolix Product Picture
 Figure 5. Relugolix Product Picture
 Figure 6. Linzagolix Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Oral GnRH Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Oral GnRH Drugs Market Share by Application: 2023 & 2030
 Figure 10. Endometriosis
 Figure 11. Uterine Fibroids
 Figure 12. Menorrhagia
 Figure 13. Other
 Figure 14. Global Oral GnRH Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Oral GnRH Drugs Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Oral GnRH Drugs Sales (2019-2030) & (K Units)
 Figure 17. Global Oral GnRH Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 18. Oral GnRH Drugs Report Years Considered
 Figure 19. Oral GnRH Drugs Sales Share by Manufacturers in 2023
 Figure 20. Global Oral GnRH Drugs Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Oral GnRH Drugs Players: Market Share by Revenue in Oral GnRH Drugs in 2023
 Figure 22. Oral GnRH Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Oral GnRH Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Oral GnRH Drugs Sales Market Share by Country (2019-2030)
 Figure 25. North America Oral GnRH Drugs Revenue Market Share by Country (2019-2030)
 Figure 26. United States Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Oral GnRH Drugs Sales Market Share by Country (2019-2030)
 Figure 29. Europe Oral GnRH Drugs Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Oral GnRH Drugs Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Oral GnRH Drugs Revenue Market Share by Region (2019-2030)
 Figure 37. China Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Oral GnRH Drugs Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Oral GnRH Drugs Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Oral GnRH Drugs Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Oral GnRH Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Oral GnRH Drugs by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Oral GnRH Drugs by Type (2019-2030)
 Figure 56. Global Oral GnRH Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Oral GnRH Drugs by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Oral GnRH Drugs by Application (2019-2030)
 Figure 59. Global Oral GnRH Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 60. Oral GnRH Drugs Value Chain
 Figure 61. Oral GnRH Drugs Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Drugs to Treat Hypertriglyceridemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37P13132
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Pseudobulbar Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11M17013
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Canine Atopic Dermatitis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13T13744
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Medications for Actinic Keratosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-36R13742
Wed Nov 06 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions